CD4 and Miyoshi myopathy: In this study, we found an obvious pathological change (increased of MM and pyroptosis sensitivity) in CD4+T cells from HAART-treated patients whose viremia was effectively suppressed, which provides a new pathway to explain the clinical phenomenon.